Related Experiment Video

Updated: Jul 14, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Expression of ral GTPases, their effectors, and activators in human bladder cancer

Steven Christopher Smith1, Gary Oxford, Alexander S Baras

  • 1Department of Molecular Physiology, University of Virginia, Charlottesville, Virginia 22908, USA.

Abstract

Insights

This study reveals RalA and RalB GTPase activation and differential expression in bladder cancer, linking prior model system findings to human disease and suggesting potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • GTPase Signaling

Background:

  • The Ral family of small G proteins (GTPases) is implicated in cancer progression.
  • Previous studies suggested roles in tumorigenesis, invasion, and metastasis in model systems.
  • A comprehensive analysis of Ral GTPase activation and expression in human tumors was lacking.

Purpose of the Study:

  • To systematically evaluate the activation state, mutation status, and expression levels of RalA and RalB in bladder cancer.
  • To correlate these findings with tumor characteristics and known oncogenic pathways.
  • To establish a link between in vitro/animal model findings and human bladder cancer.

Main Methods:

  • Assessed RalA and RalB activation in 10 bladder cancer cell lines with varying Ras mutation status.
  • Sequenced RalA and RalB cDNAs from 20 bladder cancer cell lines and functionally characterized mutations.
  • Quantified mRNA and protein expression of Ral GTPases, activators (e.g., Aurora-A), and effectors (e.g., RalBP1, Filamin A) in cell lines and tissues.

Main Results:

  • Identified one RalA E97Q mutation in 20 cell lines; observed higher Ral activation in cells with mutant HRAS.
  • Found significant overexpression of RalA and Aurora-A mRNA in bladder cancer, correlating with higher stage and grade.
  • Demonstrated overexpression of RalBP1 (mRNA/protein) and underexpression of Filamin A in bladder cancer; confirmed RalA mRNA-protein correlation and overexpression of both GTPases in invasive cancers.

Conclusions:

  • The findings demonstrate RalA and RalB activation and differential expression in human bladder cancer.
  • These results connect prior model system data to human disease.
  • Targeting the Ral GTPase pathway presents a potential therapeutic strategy for bladder cancer.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...